Ali Asif 4
4 · Protagonist Therapeutics, Inc · Filed Apr 23, 2025
Insider Transaction Report
Form 4
Ali Asif
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-22$46.00/sh−1,756$80,776→ 61,065 total
Footnotes (1)
- [F1]Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.